Search research articles
Contact Us
Filters
Showing results (31-40 of 58) with videos related to
Page
of 6
Sort By:
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
May 30, 2019
[Boost in proton for locally advanced nasopharyngeal carcinoma: A Curie Institute experience]
A Beddok, L Feuvret, G Noël, et al.
La Revue De Medecine Interne
|
February 15, 2008
[Cholangiocarcinoma: epidemiology and global management]
C Dreyer, C Le Tourneau, S Faivre, et al.
Investigational New Drugs
|
April 7, 2019
Safety and clinical activity of the Notch inhibitor, crenigacestat (LY3039478), in an open-label phase I trial expansion cohort of advanced or metastatic adenoid cystic carcinoma
C Even, U Lassen, J Merchan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 19, 2017
Hyperprogression during anti-PD-1/PD-L1 therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
E Saâda-Bouzid, C Defaucheux, A Karabajakian, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
July 21, 2019
Medical Oncology Workload in Europe: One Continent, Several Worlds
B Seruga, R Sullivan, A Fundytus, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 31, 2018
First-in-human study of LY3039478, an oral Notch signaling inhibitor in advanced or metastatic cancer
C Massard, A Azaro, J-C Soria, et al.
NPJ Precision Oncology
|
July 21, 2021
Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world population
C B Westphalen, M G Krebs, C Le Tourneau, et al.
NPJ Precision Oncology
|
September 18, 2021
Author Correction: Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world population
C B Westphalen, M G Krebs, C Le Tourneau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 16, 2017
The European Society for Medical Oncology (ESMO) Precision Medicine Glossary
L R Yates, J Seoane, C Le Tourneau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 12, 2018
Personalized biomarker-based treatment strategy for patients with squamous cell carcinoma of the head and neck: EORTC position and approach
R Galot, C Le Tourneau, J Guigay, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 58) with videos related to
Sort By:
Page
of 6
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
May 30, 2019
[Boost in proton for locally advanced nasopharyngeal carcinoma: A Curie Institute experience]
A Beddok, L Feuvret, G Noël, et al.
La Revue De Medecine Interne
|
February 15, 2008
[Cholangiocarcinoma: epidemiology and global management]
C Dreyer, C Le Tourneau, S Faivre, et al.
Investigational New Drugs
|
April 7, 2019
Safety and clinical activity of the Notch inhibitor, crenigacestat (LY3039478), in an open-label phase I trial expansion cohort of advanced or metastatic adenoid cystic carcinoma
C Even, U Lassen, J Merchan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 19, 2017
Hyperprogression during anti-PD-1/PD-L1 therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
E Saâda-Bouzid, C Defaucheux, A Karabajakian, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
July 21, 2019
Medical Oncology Workload in Europe: One Continent, Several Worlds
B Seruga, R Sullivan, A Fundytus, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 31, 2018
First-in-human study of LY3039478, an oral Notch signaling inhibitor in advanced or metastatic cancer
C Massard, A Azaro, J-C Soria, et al.
NPJ Precision Oncology
|
July 21, 2021
Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world population
C B Westphalen, M G Krebs, C Le Tourneau, et al.
NPJ Precision Oncology
|
September 18, 2021
Author Correction: Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world population
C B Westphalen, M G Krebs, C Le Tourneau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 16, 2017
The European Society for Medical Oncology (ESMO) Precision Medicine Glossary
L R Yates, J Seoane, C Le Tourneau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 12, 2018
Personalized biomarker-based treatment strategy for patients with squamous cell carcinoma of the head and neck: EORTC position and approach
R Galot, C Le Tourneau, J Guigay, et al.
Page
of 6